What You Ought to Know:
– GoodRx has unveiled two main initiatives to democratize entry to GLP-1 medicines: the launch of the GoodRx for Weight Loss telemedicine subscription and a brand new introductory money worth of $199 per thirty days for Ozempic® and Wegovy® injection pens by means of a partnership with Novo Nordisk.
GoodRx for Weight Loss Telemedicine
GoodRx for Weight Loss, a direct-to-consumer telemedicine subscription is designed to simplify and handle each step of the GLP-1 remedy journey, from preliminary session to prescription achievement. The initiative goals to ascertain a better customary for affordability and belief in weight reduction care by connecting customers solely with FDA-approved GLP-1 medicines, rejecting unproven compounded options.
Key options of the brand new telemedicine subscription embrace:
- Digital Consultations: Connects customers with licensed healthcare suppliers to find out eligibility and prescribe FDA-approved GLP-1 remedies.
- Clear Pricing: Ensures customers know the price of the medicines upfront, with out hidden charges.
- Success Choices: Affords versatile achievement, together with in-store pick-up nationwide for Wegovy or Zepbound® (tirzepatide), or handy residence supply for the Zepbound vial formulation through LillyDirect.
- Ongoing Scientific Assist: Supplies steady assist to trace progress, handle negative effects, and modify remedy as wanted.
The telemedicine subscription is out there for an introductory charge of $39 per thirty days by means of January 2026, after which the usual worth is $119 per thirty days.
Delivering Actual Financial savings on Ozempic and Wegovy
In a transfer to deal with the excessive value of GLP-1s, GoodRx is collaborating with Novo Nordisk to supply unprecedented financial savings on two extremely demanded medicines. First-time GoodRx customers who’re self-paying can entry Ozempic® (semaglutide) and Wegovy® (semaglutide) injection pens for an introductory worth of simply $199 per thirty days.
- Eligibility: This introductory worth applies to the 2 lowest doses (0.25 mg and 0.5 mg) and is legitimate for the primary two fills.
- Ongoing Value: After the preliminary two months, sufferers will transfer to a brand new customary month-to-month worth of $349 per thirty days.
- Accessibility: These diminished costs make the remedies extra inexpensive and accessible for eligible sufferers at practically all pharmacies nationwide.
“GoodRx is scaling a consumer-first mannequin for inexpensive GLP-1 remedy,” stated Wendy Barnes, President and CEO of GoodRx. “We’re dedicated to connecting customers with FDA-approved GLP-1 medicines backed by science and security, not compounded options that fall in need of these requirements. By uniting nationwide pharmacy integration, residence supply capabilities, and clear pricing in a single seamless expertise, GoodRx is creating a better customary for affordability and belief in weight reduction care.”
